Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold standard status among international drug regulators while contending with cost cuts,

Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.

Marty Makary, President Trump’s pick to be FDA commissioner, promised to step down as an adviser to various health tech, medical device, and telehealth startups if confirmed.

That's the opposite approach of Makary, whose sweeping rhetoric and biting criticism often veer into hyperbole, according to a review of recent speeches, interviews, and podcast a

Dr. Marty Makary rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV. Now the Johns Hopkins University surgeon and researcher has been nominated to lead the Food and Drug Administration.

Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional medical institutions.

If I were a Senator conducting a confirmation hearing for Dr. Marty Makary, the nominee to be the next commissioner of the Food and Drug

Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.

Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold standard status among international drug regulators while contending with cost cuts,

Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.

Marty Makary, MD, MPH, rose to national attention by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV. Now the Johns Hopkins University surgeon and researcher has been nominated to lead the FDA.

Marty Makary, President Donald Trump’s pick to lead the US Food and Drug Administration, said he’s ready to carry out the mission of instituting “radical transparency” called for by Health and Human Services Secretary Robert F.